Shulman, M., Choo, T.-H., Ohrtman, K., Pavlicova, M., Rotrosen, J., & Nunes, E. V. (2025). Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial. Drug and Alcohol Dependence, 268, 112550. https://doi.org/10.1016/j.drugalcdep.2025.112550

Shulman, M., Greiner, M. G., Tafessu, H. M., Opara, O., Ohrtman, K., Potter, K., Hefner, K., Jelstrom, E., Rosenthal, R. N., Wenzel, K., Fishman, M., Rotrosen, J., Ghitza, U. E., Nunes, E. V., & Bisaga, A. (2024). Rapid Initiation of Injection Naltrexone for Opioid Use Disorder. JAMA Network Open, 7(5), e249744. https://doi.org/10.1001/jamanetworkopen.2024.9744

Bunting, A. M., Krawczyk, N., Choo, T.-H., Pavlicova, M., McNeely, J., Tofighi, B., Rotrosen, J., Nunes, E., & Lee, J. D. (2022). Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes. Journal of Substance Abuse Treatment, 143, 108830. https://doi.org/10.1016/j.jsat.2022.108830